Cyclooxygenase‐Dependent Formation of the Isoprostane 8‐EPI Prostaglandin F_2α^a

This publication has 16 references indexed in Scilit:

• Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
  Journal of Clinical Investigation, 1994
• Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivo
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
• Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
  Proceedings of the National Academy of Sciences, 1992
• The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist
  Prostaglandins, 1992
• Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
  Journal of Clinical Investigation, 1992
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
  Proceedings of the National Academy of Sciences, 1990
• The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
  Journal of Biological Chemistry, 1990
• Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids
  Analytical Biochemistry, 1990
• Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
  Circulation, 1988
• Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
  Circulation, 1987